Intellia Therapeutics, Inc.
NTLA
Revenue
12.87M
▲3.76M▲41.30%
3 Months ChangeAssets
1.19B
▲17.66M▲1.51%
3 Months ChangeLiabilities
319.06M
▲108.32M▲51.40%
3 Months ChangeFree Cash Flow
-123.17M
▼-10.01M▼-8.84%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-25
Form 8-K
ID: 0001193125-24-244201
2024-08-08
Form 10-Q
ID: 0000950170-24-093907
2024-08-08
Form 8-K
ID: 0000950170-24-093339
2024-06-26
Form 8-K
ID: 0001193125-24-168545
2024-06-14
Form 8-K
ID: 0000950170-24-073709
2024-06-13
Form 8-K
ID: 0000950170-24-073116
2024-05-09
Form 10-Q
ID: 0000950170-24-057046
2024-05-09
Form 8-K
ID: 0000950170-24-056286
2024-04-15
Form 8-K
ID: 0000950170-24-044424
2024-03-22
Form 8-K
ID: 0001193125-24-074706